| 摘要 |
FIELD: chemistry.SUBSTANCE: invention relates to compounds of formula(I), their racemic mixture, enantiomers, diastereomers and pharmaceutically acceptable salts, possessing properties of Syk inhibitor, pharmaceutical composition and medication based thereof, thereof application, methods of inhibiting and method of treatment with thereof application. In general formula (I) Rrepresents hydrogen or C-Calkyl, Rrepresents phenyl, benzo[d][1,3]dioxolyl, 2,3-dihydrobenzo[b][1,4]dioxinyl, or 5-10-membered heteroaryl, containing 1-2 heteroatoms, selected from N and O, which is optionally substituted with one or several groups, selected from halogen, -NRR, -OR, -S(O)R, -C(O)R, -CN, -C(O)NRR, -NRC(O)R, -NRS(O)R, -S(O)NRR, C-Calkyl, optionally substituted with one, two or three groups, selected from halogen, -OH, -OC-Calkyl, -NH, -NH(C-Calkyl), -N(C-Calkyl)(C-Calkyl), -C(O)N(C-Calkyl)(C-Calkyl), or 5-8-membered heterocycle, containing 1-2 heteroatoms, selected from N, O, and S, optionally substituted with -SO(C-Calkyl), C-Ccycloalkyl, 5-8-membered heterocycle, containing 1-2 heteroatoms, selected from N, O and S, optionally substituted with one, two, or three groups, selected from halogen, -OH, C-Calkyl, -C-Calkyl-OH, ketogroup(oxo), -C(O)C-Calkyl, -C(O)C-Ccycloalkyl, -C(O)C-Ccycloalkyl-CN, -C(O)C-Ccycloalkylhalogen, -C(O)NH, -C(O)NH(C-Calkyl), -C(O)N(C-Calkyl)(C-Calkyl), -C(O)(C-Calkyl)-OH, -C(O)(C-Calkyl)-O(C-Calkyl), -C(O)C-Chalogenalkyl, -C(O)(C-Calkyl)-CN, -C(O)(C-Calkyl)-C(O)NH, -C(O)(C-Calkyl)C-Ccycloalkyl, -C(O)(C-Calkyl)-oxetane, C(O)-furanyl, -C(O)-tetrahydrofuranyl, -C(O)(C-Calkyl)-SO(C-Calkyl), -O(C-Calkyl)-OH, -SO(C-Calkyl), -SONH(C-Calkyl), -SO(C-Calkyl)(C-Calkyl), -SOC-Ccycloalkyl, -N(C-Calkyl)C(O)(C-Calkyl), and 5-6-membered heteroaryl, containing 1-2 nitrogen atoms, optionally substituted with C-Calkyl, Rand Rare independently selected from hydrogen, C-Calkyl, C-Ccycloalkyl, phenyl, 1,3-dihydroisobenzofuranyl, and 5-6-membered heterocycle, containing 1 nitrogen atom, each of which, except hydrogen, is optionally substituted with one or several groups, selected from halogen, -NRR, -OR, -C(O)OR, -CN, -C(O)NRR, -S(O)NRR, C-Calkyl, C-Ccycloalkyl, 5-6-membered heteroaryl, containing 1-2 nitrogen atoms, and 4-7-membered heterocycle, containing 1-2 heteroatoms, selected from N, O, and S, optionally substituted with one, two or three groups, selected from halogen, hydroxyl, ketogroup(oxo) C-Calkyl, -C-Calkyl-OH, -C-Chalogenalkyl, -C(O)NH, -C(O)NH(C-Calkyl), -C(O)N(C-Calkyl)(C-Calkyl), -C(O)C-Calkyl, -C(O)(C-Calkyl)-C-Ccycloalkyl, -C(O)C-Ccycloalkyl, -C(O)C-Chalogenalkyl, -C(O)(C-Calkyl)-CN, -C(O)(C-Calkyl)-OH, -C(O)(C-Calkyl)-O-(C-Calkyl), -C(O)(C-Calkyl)N(C-Calkyl), -C(O)(C-Calkyl)-SO-(C-Calkyl), -C(O)(C-Calkyl)-C-Ccycloalkyl, -SO(C-Calkyl), -SO(C-Chalogenalkyl), -SOC-Ccycloalkyl, -SONHand pyrimidinyl, or Rand Rtogether with N atom, which they bind to, can form 5-10-membered monocyclic, fused bicyclic or spirocyclic ring, optionally containing 1 additional nitrogen atom, which is optionally substituted with one or several groups, selected from -NRR, -C(O)OR, -C(O)NRR, -NRS(O)R, -NRC(O)NRR, and C-Calkyl optionally substituted with hydroxyl, amino, -NHSO(C-Calkyl), -NH(C-Calkyl), -N(C-Calkyl)(C-Calkyl), or -NHC(O)NH, m equals 0 or 1, n equals 2.EFFECT: obtaining novel compounds.28 cl, 3 ex |
